Rigo et al., showed that CXCL12-activated mononuclear phagocytes to send antiapoptotic and proliferative signals to cancer cells, while, in turn, tumor cells produced factors that polarized mononuclear phagocytes towards an M2 phenotype. The gene discussed is CXCL12; the disease is cancer.